Literature DB >> 8106379

Identification and characterization of the phosphatidylinositol-(4, 5)-bisphosphate 5-phosphatase in human platelets.

M Matzaris1, S P Jackson, K M Laxminarayan, C J Speed, C A Mitchell.   

Abstract

Phosphatidylinositol (4,5)-bisphosphate (PtdIns(4,5)-P2) is the precursor of several second messenger molecules. In unstimulated cells PtdIns(4,5)P2 is hydrolyzed by a PtdIns(4,5)P2 5-phosphatase to form phosphatidylinositol 4-phosphate (PtdIns(4)P) which is subsequently recycled to phosphatidylinositol. PtdIns(4,5)P2 5-phosphatase activity was detected in platelet cytosolic and particulate fractions. The platelet PtdIns(4,5)P2 5-phosphatase activity was magnesium but not calcium dependent. The elution profile of platelet cytosolic PtdIns(4,5)P2 5-phosphatase from anion exchange resins, exactly matched that of the 75-kDa inositol-polyphosphate 5-phosphatase (Ins(1,4,5)P3 5-phosphatase). The latter is a signal terminating enzyme responsible for the hydrolysis of inositol (1,4,5)-trisphosphate (Ins(1,4,5)P3) to inositol (1,4)-bisphosphate (Mitchell, C.A., Connolly, T.M., and Majerus, P.W. (1989) J. Biol. Chem. 264, 8873-8877). Polyclonal antibodies raised against recombinant 75-kDa Ins(1,4,5)P3 5-phosphatase specifically immunoprecipitated all PtdIns-(4,5)P2 5-phosphatase activity from both the platelet membrane and cytosolic fractions. Purified 75-kDa Ins(1,4,5)P3 5-phosphatase hydrolyzed PtdIns(4,5)P2 forming PtdIns(4)P (Km = 250 microM). By contrast, purified membrane-associated 43-kDa Ins(1,4,5)P3 5-phosphatase did not hydrolyze PtdIns(4,5)P2. In the unstimulated platelet, recycling of PtdIns-(4,5)P2 to PtdIns(4)P is mediated by the 75-kDa Ins-(1,4,5)P3 5-phosphatase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106379

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  The yeast inositol polyphosphate 5-phosphatases inp52p and inp53p translocate to actin patches following hyperosmotic stress: mechanism for regulating phosphatidylinositol 4,5-bisphosphate at plasma membrane invaginations.

Authors:  L M Ooms; B K McColl; F Wiradjaja; A P Wijayaratnam; P Gleeson; M J Gething; J Sambrook; C A Mitchell
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.

Authors:  Yuxin Mao; Daniel M Balkin; Roberto Zoncu; Kai S Erdmann; Livia Tomasini; Fenghua Hu; Moonsoo M Jin; Michael E Hodsdon; Pietro De Camilli
Journal:  EMBO J       Date:  2009-06-18       Impact factor: 11.598

3.  Clinical utility gene card for: Lowe syndrome.

Authors:  Arend Bökenkamp; Elena Levtchenko; Florian Recker; Michael Ludwig
Journal:  Eur J Hum Genet       Date:  2014-09-03       Impact factor: 4.246

Review 4.  The structure of phosphoinositide phosphatases: Insights into substrate specificity and catalysis.

Authors:  FoSheng Hsu; Yuxin Mao
Journal:  Biochim Biophys Acta       Date:  2014-09-28

5.  Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.

Authors:  P A Jänne; S F Suchy; D Bernard; M MacDonald; J Crawley; A Grinberg; A Wynshaw-Boris; H Westphal; R L Nussbaum
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

6.  Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.

Authors:  T Lin; B M Orrison; A M Leahey; S F Suchy; D J Bernard; R A Lewis; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

7.  Phosphatidylinositol 4,5-bisphosphate phosphatase regulates the rearrangement of actin filaments.

Authors:  T Sakisaka; T Itoh; K Miura; T Takenawa
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

8.  Yersinia entry into host cells requires Rab5-dependent dephosphorylation of PI(4,5)P₂ and membrane scission.

Authors:  Helen Sarantis; Daniel M Balkin; Pietro De Camilli; Ralph R Isberg; John H Brumell; Sergio Grinstein
Journal:  Cell Host Microbe       Date:  2012-02-16       Impact factor: 21.023

9.  Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.

Authors:  Florian Recker; Marcin Zaniew; Detlef Böckenhauer; Nunzia Miglietti; Arend Bökenkamp; Anna Moczulska; Anna Rogowska-Kalisz; Guido Laube; Valerie Said-Conti; Belde Kasap-Demir; Anna Niemirska; Mieczysław Litwin; Grzegorz Siteń; Krystyna H Chrzanowska; Małgorzata Krajewska-Walasek; Sidharth K Sethi; Velibor Tasic; Franca Anglani; Maria Addis; Anna Wasilewska; Maria Szczepańska; Krzysztof Pawlaczyk; Przemysław Sikora; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

10.  Up-regulation of phosphoinositide metabolism in tobacco cells constitutively expressing the human type I inositol polyphosphate 5-phosphatase.

Authors:  Imara Y Perera; John Love; Ingo Heilmann; William F Thompson; Wendy F Boss
Journal:  Plant Physiol       Date:  2002-08       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.